Cresco Labs Inc. - Understand $crlbf stock

$CRLBF Market Cap: $947 Million

Research Board Inbox Deep Research Not Interested Shortlisted

Financial Snapshot

Revenue

$747.4M

TTM

Gross Margin

50.42%

TTM

Net Earnings

-$172.5M

TTM

Current Assets

$273.4M

Q2 2024

Current Liabilities

$136.9M

Q2 2024

Current Ratio

199.72%

Q2 2024

Total Assets

$1.358B

Q2 2024

Total Liabilities

$890.4M

Q2 2024

Book Value

$467.7M

Q2 2024

Cash

$112.3M

Q2 2024

P/E

-5.491

Nov 29, 2024 EST

Free Cash Flow

$51.80M

TTM

Revenues

Revenue YoY Change

Revenues

Concept	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009	2008	2007	2006	2005	2004	2003	2002	2001	2000	1999	1998	1997	1996
Revenue	$770.9M	$842.7M	$821.7M	$476.3M	$128.5M	$43.25M	$0.00	$0.00		$0.00
YoY Change	-8.52%	2.56%	72.53%	270.53%	197.17%

Expenses

Cost Of Revenues

Gross Profit

Gross Profit Margin

Gross Profit

Concept	2023	2022	2021	2020	2019	2018	2017	2016	2014
Revenue	$770.9M	$842.7M	$821.7M	$476.3M	$128.5M	$43.25M	$0.00	$0.00	$0.00
Cost Of Revenue	$408.5M	$435.7M	$415.3M	$269.6M	$82.90M	$55.40M			$0.00
Gross Profit	$362.4M	$407.0M	$406.3M	$206.7M	$45.63M	-$12.15M			$0.00
Gross Profit Margin	47.01%	48.3%	49.45%	43.4%	35.5%	-28.08%

Selling, General & Admin Expense

Research & Development

Depreciation, Depletion & Amortization

SGA Expense to Gross Profit Ratio

R&D To Gross Profit Ratio

DDA To Gross Profit Ratio

Operating Expenses Total

Operating Profits/Loss

Operational Expenses

Concept	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009	2008	2007	2006	2005	2004	2002	2001	2000	1999	1998	1997
Selling, General & Admin	$274.6M	$330.0M	$296.2M	$211.8M	$94.12M	$31.29M	$42.50K	$43.54K		$38.68K
YoY Change	-16.78%	11.42%	39.84%	125.05%	200.82%	73509.54%	-2.39%
% of Gross Profit	75.79%	81.08%	72.89%	102.47%	206.26%
Research & Development										$9.768K
YoY Change
% of Gross Profit
Depreciation & Amortization	$62.51M	$51.93M	$38.64M	$31.79M	$11.91M	$2.172M	$0.00	$16.00	$69.00	$78.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$40.00K	$50.00K	$30.00K	$10.00K	$0.00
YoY Change	20.38%	34.39%	21.56%	166.9%	448.34%		-100.0%	-76.81%	-11.54%												-100.0%	-20.0%	66.67%	200.0%
% of Gross Profit	17.25%	12.76%	9.51%	15.38%	26.1%
Operating Expenses	$299.2M	$350.7M	$317.8M	$228.9M	$98.34M	$31.98M	$42.50K	$43.56K		$46.40K
YoY Change	-14.68%	10.34%	38.81%	132.82%	207.5%	75139.39%	-2.42%
Operating Profit	$63.19M	$56.36M	$88.54M	-$22.25M	-$52.71M	-$44.13M				-$46.40K
YoY Change	12.13%	-36.35%	-498.04%	-57.79%	19.45%

Interest Expenses

Interest Expenses To Operating Income %

Other Expense/Income

Interest & Other Expense/Income

Concept	2023	2022	2021	2020	2019	2018	2017	2016	2014
Interest Expense	-$57.21M	-$62.06M	-$15.04M	-$35.09M	-$11.47M	$3.258M	-$39.81K	-$31.32K	-$28.50K
YoY Change	-7.82%	312.63%	-57.14%	205.89%	-452.09%	-8284.9%	27.1%
% of Operating Profit	-90.52%	-110.11%	-16.98%
Other Income/Expense, Net	-$3.898M	-$141.0K	-$5.464M	-$4.505M	-$1.407M	-$736.0K			$0.00
YoY Change	2664.54%	-97.42%	21.29%	220.18%	91.17%

Income/Loss

Pretax Income

Income Tax

Net Profits/Loss

Pretax Income YoY Change

Income Tax Rate

Net Profits/Loss YoY Change

Basic EPS

Net Income To Revenue Ratio

Pretax & Net Income

Concept	2023	2022	2021	2020	2019	2018	2017	2016	2014
Pretax Income	-$146.9M	-$126.9M	-$256.7M	-$64.17M	-$50.84M	$7.467M	-$81.67K	-$109.8K	-$74.32K
YoY Change	15.76%	-50.57%	300.09%	26.21%	-780.88%	-9242.67%	-25.62%
Income Tax	$32.95M	$88.94M	$40.11M	$28.60M	$14.46M	$4.374M			$0.00
% Of Pretax Income						58.58%
Net Earnings	-$175.5M	-$212.0M	-$319.6M	-$102.2M	-$43.20M	-$1.915M	-$81.67K	-$109.8K	-$74.32K
YoY Change	-17.22%	-33.65%	212.85%	136.47%	2155.93%	2244.74%	-25.62%
Net Earnings / Revenue	-22.77%	-25.16%	-38.9%	-21.45%	-33.61%	-4.43%
Basic Earnings Per Share
Diluted Earnings Per Share	-$0.54	-$0.71	-$1.218M	-$485.4K	-$365.1K	-$32.27K	-$2.889K	-$3.884K	-$2.628K

Assets & Liabilities

Cash & Short-Term Investments

Cash & Equivalents

Cash To Operating Expenses Ratio

Inventory

Receivables

Total Short-Term Assets

Property, Plant And Equipment

Long-Term Investments

Total Long-Term Assets

Total Assets

Net Income To Total Assets Percentage

Accounts Payable

Short-Term Debt

Long Term Debt Due

Total Short-Term Liabilities

Long-Term Debt

Other Long-Term Liabilities

Total Long-Term Liabilities

Total Liabilities

Short-Term To Long-Term Debt Ratio

Short-Term Assets To Debt Ratio

Long-Term Debt To Net Income Ratio

Assets & Liabilities

Concept	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009	2008	2007	2006	2005	2004	2003	2002	2001	2000	1999	1998	1997	1996
Cash & Short-Term Investments	$103.4M	$119.3M	$223.5M	$136.3M	$49.10M	$131.3M	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$100.0K	$200.0K	$400.0K	$100.0K	$400.0K	$1.200M	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
YoY Change	-13.33%	-46.61%	63.96%	177.66%	-62.6%									-100.0%	-50.0%	-50.0%	300.0%	-75.0%	-66.67%
Cash & Equivalents	$103.4M	$119.3M	$223.5M	$136.3M	$49.10M	$131.3M	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00							$1.200M	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Short-Term Investments													$0.00	$0.00	$0.00	$200.0K	$100.0K	$0.00	$100.0K	$0.00
Other Short-Term Assets	$14.38M	$15.16M	$16.88M	$13.56M	$11.79M	$25.50M	$0.00	$74.61K		$0.00	$0.00	$0.00	$0.00		$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$600.0K
YoY Change	-5.15%	-10.19%	24.43%	15.04%	-53.76%		-100.0%													-100.0%
Inventory	$107.8M	$134.6M	$136.6M	$67.18M	$81.35M	$24.52M				$0.00
Prepaid Expenses
Receivables	$51.07M	$56.49M	$43.38M	$29.94M	$16.45M	$3.658M	$1.761K			$0.00
Other Receivables	$1.421M	$447.0K	$1.312M	$2.438M	$644.0K	$7.726M	$0.00			$4.891K
Total Short-Term Assets	$278.1M	$326.0M	$421.8M	$249.5M	$159.3M	$192.7M	$1.761K	$76.99K	$2.079K	$4.891K	$0.00	$0.00	$0.00	$0.00	$100.0K	$300.0K	$700.0K	$100.0K	$400.0K	$1.300M	$500.0K	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
YoY Change	-14.71%	-22.69%	69.06%	56.56%	-17.31%	10942773.37%	-97.71%	3603.13%	-57.49%					-100.0%	-66.67%	-57.14%	600.0%	-75.0%	-69.23%	160.0%
Property, Plant & Equipment	$486.2M	$508.0M	$457.1M	$300.6M	$202.5M	$39.72M			$117.2K	$0.00	$100.0K	$200.0K	$200.0K	$400.0K	$2.400M	$4.000M	$600.0K	$500.0K	$600.0K	$100.0K	$100.0K	$100.0K	$100.0K	$100.0K	$100.0K	$100.0K	$800.0K	$800.0K
YoY Change	-4.29%	11.13%	52.07%	48.42%	409.89%					-100.0%	-50.0%	0.0%	-50.0%	-83.33%	-40.0%	566.67%	20.0%	-16.67%	500.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	-87.5%	0.0%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$730.0K	$1.228M	$5.912M	$4.360M	$1.278M	$433.0K				$0.00
YoY Change	-40.55%	-79.23%	35.6%	241.16%	195.15%
Other Assets	$15.97M	$9.464M	$10.77M	$10.84M	$2.845M	$1.363M				$0.00	$0.00	$0.00	$0.00				$5.800M	$4.400M	$3.900M	$1.400M	$300.0K	$300.0K	$300.0K	$200.0K	$300.0K	$100.0K	$200.0K	$400.0K
YoY Change	68.76%	-12.13%	-0.62%	280.95%	108.73%												31.82%	12.82%	178.57%	366.67%	0.0%	0.0%	50.0%	-33.33%	200.0%	-50.0%	-50.0%
Total Long-Term Assets	$1.080B	$1.258B	$1.359B	$983.1M	$457.2M	$125.4M	$0.00	$0.00	$117.2K	$108.3K	$200.0K	$200.0K	$200.0K	$400.0K	$2.400M	$4.000M	$6.400M	$4.900M	$4.600M	$1.500M	$400.0K	$400.0K	$300.0K	$400.0K	$500.0K	$200.0K	$1.000M	$1.200M
YoY Change	-14.1%	-7.44%	38.2%	115.03%	264.59%			-100.0%	8.26%	-45.86%	0.0%	0.0%	-50.0%	-83.33%	-40.0%	-37.5%	30.61%	6.52%	206.67%	275.0%	0.0%	33.33%	-25.0%	-20.0%	150.0%	-80.0%	-16.67%
Total Assets	$1.358B	$1.584B	$1.780B	$1.233B	$616.6M	$318.1M	$1.761K	$76.99K	$119.3K	$113.2K	$200.0K	$200.0K	$200.0K	$400.0K	$2.500M	$4.300M	$7.100M	$5.000M	$5.000M	$2.800M	$900.0K	$400.0K	$300.0K	$400.0K	$500.0K	$200.0K	$1.000M	$1.200M
YoY Change
Accounts Payable	$27.59M	$28.09M	$32.28M	$23.23M	$32.46M	$7.595M	$232.5K	$234.4K	$223.1K	$191.4K	$200.0K	$300.0K	$400.0K	$700.0K	$800.0K	$600.0K	$500.0K	$400.0K	$300.0K	$200.0K	$100.0K	$200.0K	$200.0K	$200.0K	$100.0K	$100.0K	$100.0K	$0.00
YoY Change	-1.8%	-12.97%	38.94%	-28.44%	327.43%	3166.36%	-0.79%	5.07%	16.56%	-4.31%	-33.33%	-25.0%	-42.86%	-12.5%	33.33%	20.0%	25.0%	33.33%	50.0%	100.0%	-50.0%	0.0%	0.0%	100.0%	0.0%	0.0%
Accrued Expenses	$69.08M	$65.16M	$95.44M	$130.5M	$29.92M
YoY Change	6.01%	-31.73%	-26.85%	336.12%
Deferred Revenue
YoY Change
Short-Term Debt	$11.82M	$18.81M	$19.93M	$25.92M	$0.00	$0.00	$285.2K	$0.00	$0.00	$92.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
YoY Change	-37.18%	-5.6%	-23.13%			-100.0%			-100.0%
Long-Term Debt Due	$9.416M	$26.12M	$20.79M	$18.04M	$12.02M
YoY Change	-63.96%	25.64%	15.25%	50.1%
Total Short-Term Liabilities	$200.2M	$280.9M	$288.4M	$252.8M	$150.2M	$25.23M	$1.020M	$1.013M	$934.0K	$912.1K	$1.100M	$1.000M	$700.0K	$900.0K	$900.0K	$900.0K	$500.0K	$500.0K	$300.0K	$200.0K	$100.0K	$200.0K	$200.0K	$400.0K	$400.0K	$300.0K	$200.0K	$200.0K
YoY Change	-28.71%	-2.61%	14.06%	68.37%	495.2%	2373.88%	0.64%	8.5%	2.41%	-17.08%	10.0%	42.86%	-22.22%	0.0%	0.0%	80.0%	0.0%	66.67%	50.0%	100.0%	-50.0%	0.0%	-50.0%	0.0%	33.33%	50.0%	0.0%
Long-Term Debt	$661.5M	$625.2M	$584.0M	$329.9M	$83.41M	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$200.0K	$100.0K	$0.00	$0.00	$0.00	$0.00	$0.00	$200.0K	$200.0K	$200.0K	$300.0K	$100.0K	$100.0K	$0.00	$0.00
YoY Change	5.8%	7.06%	77.02%	295.54%									-100.0%	100.0%						-100.0%	0.0%	0.0%	-33.33%	200.0%	0.0%
Other Long-Term Liabilities	$28.18M	$14.77M	$24.65M	$33.31M	$37.14M	$5.441M				$0.00
YoY Change	90.77%	-40.09%	-25.99%	-10.32%	582.67%
Total Long-Term Liabilities	$689.7M	$640.0M	$608.7M	$363.2M	$120.6M	$5.441M	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$200.0K	$100.0K	$0.00	$0.00	$0.00	$0.00	$0.00	$200.0K	$200.0K	$200.0K	$300.0K	$100.0K	$100.0K	$0.00	$0.00
YoY Change	7.76%	5.15%	67.58%	201.3%	2115.59%								-100.0%	100.0%						-100.0%	0.0%	0.0%	-33.33%	200.0%	0.0%
Total Liabilities	$852.8M	$956.7M	$1.025B	$759.4M	$429.5M	$197.1M	$1.020M	$1.013M	$934.0K	$912.1K	$1.100M	$1.000M	$700.0K	$1.100M	$1.000M	$900.0K	$500.0K	$500.0K	$300.0K	$200.0K	$200.0K	$400.0K	$500.0K	$700.0K	$500.0K	$400.0K	$200.0K	$200.0K
YoY Change	-10.86%	-6.66%	34.97%	76.81%	117.92%	19224.3%	0.64%	8.5%	2.41%	-17.08%	10.0%	42.86%	-36.36%	10.0%	11.11%	80.0%	0.0%	66.67%	50.0%	0.0%	-50.0%	-20.0%	-28.57%	40.0%	25.0%	100.0%	0.0%

Ownership

Basic Shares Outstanding

Diluted Shares Outstanding

Preferred Stock

Treasury Stock Shares

Stock Issuance & Repurchase

Ownership Data

Concept	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009	2008	2007	2006	2005	2004	2003	2002	2001	2000	1999	1998	1997	1996
Basic Shares Outstanding
Diluted Shares Outstanding
Preferred Stock
Treasury Stock Shares

Return On Shareholders' Equity

Book Value

Free Cash Flow

Free Cash Flow YoY

Free Cash Flow Margin

Dividends

Stock Price

Market Cap: $947.02 Million

About Cresco Labs Inc.

Cresco Labs Inc. engages in cultivating medical grade cannabis, manufacturing medical products derived from cannabis cultivation, and distributing such products to medical or adult use consumers. The company is headquartered in Chicago, Illinois and currently employs 2,760 full-time employees. The company went IPO on 2018-12-03. The firm is licensed to cultivate, manufacture, and sell retail and medical cannabis products primarily through Sunnyside, Cresco Labs’ national dispensary brand, and third-party retail stores. Its family brands include Cresco, High Supply, Good News, Wonder Wellness Co., FloraCal Farms, Remedi and Mindy’s. Its portfolio consists of over 400 products. The firm's products are sold in over 1,600 dispensaries across the country. Its Cresco offers consistent strains, available in a variety of product forms at dispensaries and retail locations nationwide. Its High Supply lab-tested; and available in vape carts, vape pens, flower, popcorn, shake, shorties and concentrates. Its Remedi products provide a consistent and trusted alternative to traditional pharmaceuticals like opioids. Its Mindy’s offers dosed edibles created by James Beard. The company is the wholesaler of branded cannabis products.

Industry: Medicinal Chemicals & Botanical Products Peers: Amphastar Pharmaceuticals, Inc. Amylyx Pharmaceuticals, Inc. CinCor Pharma, Inc. JOHNSON & JOHNSON NGM BIOPHARMACEUTICALS INC Revance Therapeutics, Inc. SUPERNUS PHARMACEUTICALS, INC. Tilray Brands, Inc.